Article Versions Notes

Vágvölgyi M, Girst G, Kúsz N, Ötvös SB, Fülöp F, Hohmann J, Servais J-Y, Seguin-Devaux C, Chang F-R, Chen MS, et al. Less Cytotoxic Protoflavones as Antiviral Agents: Protoapigenone 1′-O-isopropyl ether Shows Improved Selectivity Against the Epstein–Barr Virus Lytic Cycle. International Journal of Molecular Sciences. 2019; 20(24):6269. https://doi.org/10.3390/ijms20246269

Vágvölgyi, Máté, Gábor Girst, Norbert Kúsz, Sándor B. Ötvös, Ferenc Fülöp, Judit Hohmann, Jean-Yves Servais, Carole Seguin-Devaux, Fang-Rong Chang, Michael S. Chen, and et al. 2019. "Less Cytotoxic Protoflavones as Antiviral Agents: Protoapigenone 1′-O-isopropyl ether Shows Improved Selectivity Against the Epstein–Barr Virus Lytic Cycle" International Journal of Molecular Sciences 20, no. 24: 6269. https://doi.org/10.3390/ijms20246269

Vágvölgyi, M., Girst, G., Kúsz, N., Ötvös, S. B., Fülöp, F., Hohmann, J., Servais, J. -Y., Seguin-Devaux, C., Chang, F. -R., Chen, M. S., Chang, L. -K., & Hunyadi, A. (2019). Less Cytotoxic Protoflavones as Antiviral Agents: Protoapigenone 1′-O-isopropyl ether Shows Improved Selectivity Against the Epstein–Barr Virus Lytic Cycle. International Journal of Molecular Sciences, 20(24), 6269. https://doi.org/10.3390/ijms20246269